The Center for Lyme Action has appointed Meghan Bradshaw, MPH, as its new executive director.

The move marks a leadership transition for the national advocacy organization, which is focused on increasing federal funding for Lyme and other tick‑borne diseases.

Bradshaw previously led government relations for CLA and has been closely involved in advancing Lyme‑related policy on Capitol Hill.

Her background includes federal advocacy, coalition building, and public‑health policy, experience the organization says will help strengthen efforts to elevate Lyme and tick‑borne diseases as national priorities.

“With the help of nearly 10,000 advocates, Center for Lyme Action has had a remarkable run in the last six years through increases of more than $500 million for Lyme, alpha‑gal, and tick‑borne diseases,” Bradshaw said in a statement.

She added that she plans to continue pushing for expanded federal investment, including through initiatives tied to the Kay Hagan Tick Act.

Bonnie Crater, who co‑founded the organization with her brother Jeff Crater, said the board is confident in Bradshaw’s leadership.

“From the very beginning, Meghan was a dedicated advocate, but as a patient, she worked on appropriations forms from her bed,” Crater said. “She went on to earn a master’s in public health and led Center for Lyme Action’s government relations with success.”

Crater, Jeff Crater, and Monika Cheney will remain on the organization’s governing board.

Virtual Advocacy Day set for February 18

The Center for Lyme Action also announced plans for its annual Virtual Advocacy Day on February 18. The event brings together patients, clinicians, researchers, and advocates to meet with members of Congress and staff via Zoom.

Participants will share personal experiences, highlight gaps in research and surveillance, and call for increased federal funding for prevention, diagnostics, and treatment of Lyme, alpha‑gal syndrome, and other tick‑borne illnesses. Click here for registration, which is open through January 30.